Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biostage, Inc. stock logo
BSTG
Biostage
$4.45
$4.45
$4.45
$4.45
$61.78M-1.021,847 shsN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$29.95
-9.4%
$30.00
$5.17
$39.50
$256.37M1.19143,926 shs955,364 shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$10.34
+1.0%
$10.87
$8.61
$21.10
$240.41M0.95259,176 shs276,781 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$9.26
+2.9%
$8.99
$8.15
$22.40
$257.89M2.1193,738 shs276,887 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biostage, Inc. stock logo
BSTG
Biostage
0.00%0.00%0.00%0.00%0.00%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
0.00%-11.07%+13.45%-15.32%+2,994,999,900.00%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
0.00%+3.71%+3.09%-21.79%-13.40%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%+5.35%+1.09%-14.26%-49.26%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biostage, Inc. stock logo
BSTG
Biostage
N/AN/AN/AN/AN/AN/AN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/AN/AN/AN/AN/AN/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
3.2771 of 5 stars
3.01.00.00.02.02.53.1
ZimVie Inc. stock logo
ZIMV
ZimVie
2.459 of 5 stars
3.33.00.00.02.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biostage, Inc. stock logo
BSTG
Biostage
0.00
N/AN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
0.00
N/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.00
Hold$16.0054.74% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.67
Moderate Buy$16.3376.39% Upside

Current Analyst Ratings Breakdown

Latest BSTG, SNWV, ZIMV, and TCMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
5/7/2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/6/2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$25.00 ➝ $14.00
4/10/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$16.00
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biostage, Inc. stock logo
BSTG
Biostage
N/AN/AN/AN/A($0.26) per shareN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$32.63M7.86N/AN/A($1.49) per share-20.10
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$292.98M0.82$1.08 per share9.55$9.03 per share1.15
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M0.57$1.86 per share4.99$13.83 per share0.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biostage, Inc. stock logo
BSTG
Biostage
-$6.07M-$0.58N/AN/AN/AN/A-174.43%N/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-$31.37M-$4.56N/AN/A-89.86%N/A-145.76%N/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$16.96M$0.6615.6712.31N/A5.52%8.41%6.10%8/4/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.71N/AN/A-4.40%5.53%2.84%7/31/2025 (Estimated)

Latest BSTG, SNWV, ZIMV, and TCMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2025Q1 2025
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/A-$0.66N/A-$0.66N/A$9.34 million
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
5/5/2025Q1 2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
-$0.07-$0.13-$0.06-$0.13$63.48 million$61.27 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biostage, Inc. stock logo
BSTG
Biostage
N/AN/AN/AN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/AN/AN/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biostage, Inc. stock logo
BSTG
Biostage
N/A
2.73
2.73
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/A
0.40
0.28
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
0.11
4.52
3.99
ZimVie Inc. stock logo
ZIMV
ZimVie
0.58
2.14
1.48

Institutional Ownership

CompanyInstitutional Ownership
Biostage, Inc. stock logo
BSTG
Biostage
N/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
42.53%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
83.43%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Biostage, Inc. stock logo
BSTG
Biostage
15.30%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
36.60%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.50%
ZimVie Inc. stock logo
ZIMV
ZimVie
5.41%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biostage, Inc. stock logo
BSTG
Biostage
713.88 million11.76 millionNot Optionable
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
408.56 million5.43 millionN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
1,03723.25 million22.67 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77027.85 million26.34 millionOptionable

Recent News About These Companies

Wall Street Zen Upgrades ZimVie (NASDAQ:ZIMV) to "Strong-Buy"
ZimVie: Screening Cheap (Rating Upgrade)
ZimVie Inc. (ZIMV) Q1 2025 Earnings Call Transcript
ZimVie Reports First Quarter 2025 Financial Results
Q1 2025 ZimVie Inc Earnings Call
ZimVie announces launch of its Immediate Molar Implant system in US
ZimVie launches molar implant system
Needham Remains a Hold on ZimVie Inc (ZIMV)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biostage stock logo

Biostage OTCMKTS:BSTG

$4.45 0.00 (0.00%)
As of 07/24/2023

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.

Sanuwave Health stock logo

Sanuwave Health NASDAQ:SNWV

$29.95 -3.09 (-9.35%)
As of 06/27/2025 04:00 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

Tactile Systems Technology stock logo

Tactile Systems Technology NASDAQ:TCMD

$10.34 +0.10 (+0.98%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$10.34 0.00 (0.00%)
As of 06/27/2025 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$9.26 +0.26 (+2.89%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$9.27 +0.01 (+0.11%)
As of 06/27/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.